| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placebo Effect | 84 | 2023 | 511 | 12.800 |
Why?
|
| Acupuncture Therapy | 58 | 2024 | 480 | 8.270 |
Why?
|
| Placebos | 62 | 2024 | 1672 | 8.170 |
Why?
|
| Irritable Bowel Syndrome | 25 | 2022 | 452 | 4.160 |
Why?
|
| Complementary Therapies | 34 | 2015 | 487 | 2.930 |
Why?
|
| Randomized Controlled Trials as Topic | 50 | 2024 | 10340 | 1.960 |
Why?
|
| Catechol O-Methyltransferase | 10 | 2019 | 251 | 1.890 |
Why?
|
| Acupuncture | 15 | 2014 | 90 | 1.640 |
Why?
|
| Low Back Pain | 17 | 2021 | 979 | 1.520 |
Why?
|
| Acupuncture Points | 13 | 2024 | 111 | 1.490 |
Why?
|
| Physician-Patient Relations | 20 | 2021 | 3242 | 1.390 |
Why?
|
| Informed Consent | 9 | 2017 | 1007 | 1.340 |
Why?
|
| Pain | 26 | 2022 | 5066 | 1.170 |
Why?
|
| Pain Measurement | 32 | 2022 | 3514 | 1.080 |
Why?
|
| Evidence-Based Medicine | 18 | 2017 | 3696 | 1.050 |
Why?
|
| Deception | 4 | 2020 | 98 | 1.040 |
Why?
|
| Acupuncture Analgesia | 11 | 2015 | 63 | 1.010 |
Why?
|
| Pharmacogenetics | 4 | 2020 | 680 | 1.000 |
Why?
|
| Herbal Medicine | 4 | 2013 | 36 | 0.930 |
Why?
|
| Research Subjects | 6 | 2012 | 249 | 0.930 |
Why?
|
| Medicine, Traditional | 5 | 2015 | 89 | 0.870 |
Why?
|
| Methadone | 2 | 2023 | 320 | 0.860 |
Why?
|
| Double-Blind Method | 44 | 2023 | 12412 | 0.830 |
Why?
|
| Research Design | 24 | 2022 | 6181 | 0.830 |
Why?
|
| Drugs, Chinese Herbal | 8 | 2016 | 151 | 0.820 |
Why?
|
| Clinical Trials as Topic | 18 | 2018 | 8058 | 0.810 |
Why?
|
| Biomedical Research | 10 | 2019 | 3421 | 0.800 |
Why?
|
| Amitriptyline | 3 | 2010 | 112 | 0.760 |
Why?
|
| Ethics, Research | 5 | 2017 | 178 | 0.740 |
Why?
|
| Medicine, Chinese Traditional | 7 | 2022 | 73 | 0.740 |
Why?
|
| Ethics, Medical | 9 | 2020 | 787 | 0.740 |
Why?
|
| Empathy | 6 | 2023 | 473 | 0.690 |
Why?
|
| Humans | 289 | 2024 | 760261 | 0.670 |
Why?
|
| Mental Healing | 4 | 2009 | 28 | 0.660 |
Why?
|
| Physicians | 11 | 2023 | 4590 | 0.650 |
Why?
|
| Pain Perception | 8 | 2020 | 196 | 0.630 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2019 | 162 | 0.620 |
Why?
|
| General Practitioners | 3 | 2019 | 102 | 0.620 |
Why?
|
| Controlled Clinical Trials as Topic | 4 | 2006 | 186 | 0.580 |
Why?
|
| Tai Ji | 4 | 2010 | 287 | 0.580 |
Why?
|
| Treatment Outcome | 60 | 2024 | 64947 | 0.570 |
Why?
|
| Brain Mapping | 21 | 2023 | 6562 | 0.570 |
Why?
|
| Brain | 25 | 2023 | 26912 | 0.550 |
Why?
|
| Bioethical Issues | 1 | 2018 | 120 | 0.550 |
Why?
|
| Bayes Theorem | 3 | 2020 | 2325 | 0.550 |
Why?
|
| Patients | 3 | 2009 | 906 | 0.540 |
Why?
|
| Somatosensory Cortex | 5 | 2020 | 511 | 0.540 |
Why?
|
| Professional-Patient Relations | 5 | 2020 | 725 | 0.540 |
Why?
|
| Beneficence | 2 | 2016 | 54 | 0.520 |
Why?
|
| Hyperalgesia | 5 | 2021 | 530 | 0.520 |
Why?
|
| Neck Pain | 3 | 2024 | 186 | 0.520 |
Why?
|
| Arthralgia | 5 | 2018 | 461 | 0.510 |
Why?
|
| Patient Selection | 6 | 2017 | 4276 | 0.510 |
Why?
|
| Antitussive Agents | 1 | 2015 | 18 | 0.510 |
Why?
|
| Attitude to Health | 9 | 2019 | 2028 | 0.500 |
Why?
|
| Ethics, Clinical | 1 | 2016 | 101 | 0.500 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 2022 | 432 | 0.490 |
Why?
|
| Integrative Medicine | 4 | 2020 | 87 | 0.480 |
Why?
|
| Single-Blind Method | 10 | 2023 | 1577 | 0.480 |
Why?
|
| Adult | 116 | 2024 | 219847 | 0.480 |
Why?
|
| Communication | 10 | 2020 | 3846 | 0.470 |
Why?
|
| Needles | 4 | 2020 | 451 | 0.470 |
Why?
|
| Plant Extracts | 2 | 2010 | 495 | 0.470 |
Why?
|
| Pain Threshold | 8 | 2020 | 600 | 0.460 |
Why?
|
| Phytotherapy | 5 | 2015 | 295 | 0.460 |
Why?
|
| Prefrontal Cortex | 7 | 2021 | 2212 | 0.460 |
Why?
|
| Hot Flashes | 3 | 2022 | 327 | 0.460 |
Why?
|
| Perception | 3 | 2019 | 1194 | 0.450 |
Why?
|
| Medicine | 3 | 2019 | 943 | 0.450 |
Why?
|
| Physical Stimulation | 6 | 2019 | 518 | 0.440 |
Why?
|
| Anticonvulsants | 1 | 2023 | 1881 | 0.440 |
Why?
|
| Qi | 3 | 2008 | 15 | 0.440 |
Why?
|
| Anticipation, Psychological | 3 | 2017 | 85 | 0.440 |
Why?
|
| Patient Participation | 3 | 2017 | 1437 | 0.430 |
Why?
|
| Opioid-Related Disorders | 3 | 2023 | 2135 | 0.430 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2020 | 3967 | 0.420 |
Why?
|
| Disclosure | 2 | 2017 | 738 | 0.420 |
Why?
|
| Analgesia | 5 | 2021 | 459 | 0.410 |
Why?
|
| Female | 135 | 2024 | 391011 | 0.400 |
Why?
|
| Vulvodynia | 2 | 2022 | 7 | 0.400 |
Why?
|
| Male | 122 | 2024 | 359413 | 0.390 |
Why?
|
| Ceremonial Behavior | 1 | 2011 | 17 | 0.390 |
Why?
|
| Hypnosis | 2 | 2009 | 82 | 0.390 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 8 | 0.380 |
Why?
|
| Nerve Net | 7 | 2020 | 2258 | 0.380 |
Why?
|
| Meditation | 4 | 2019 | 251 | 0.380 |
Why?
|
| Cough | 1 | 2015 | 595 | 0.370 |
Why?
|
| Homeopathy | 4 | 2016 | 30 | 0.370 |
Why?
|
| Neural Pathways | 9 | 2020 | 3039 | 0.370 |
Why?
|
| Subcutaneous Tissue | 1 | 2011 | 132 | 0.360 |
Why?
|
| Research | 8 | 2021 | 1973 | 0.360 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2013 | 370 | 0.360 |
Why?
|
| Gyrus Cinguli | 4 | 2021 | 1113 | 0.360 |
Why?
|
| Patient Satisfaction | 10 | 2016 | 3451 | 0.360 |
Why?
|
| Clinical Medicine | 3 | 2009 | 145 | 0.360 |
Why?
|
| Albuterol | 1 | 2011 | 212 | 0.360 |
Why?
|
| Medicine, East Asian Traditional | 2 | 2007 | 18 | 0.350 |
Why?
|
| Attitude of Health Personnel | 12 | 2023 | 3870 | 0.350 |
Why?
|
| Middle Aged | 88 | 2024 | 220175 | 0.350 |
Why?
|
| Witchcraft | 1 | 2009 | 7 | 0.350 |
Why?
|
| Terminology as Topic | 2 | 2012 | 1534 | 0.350 |
Why?
|
| Interviews as Topic | 9 | 2017 | 2656 | 0.350 |
Why?
|
| Religion and Medicine | 4 | 2019 | 160 | 0.340 |
Why?
|
| Dyspepsia | 2 | 2023 | 118 | 0.340 |
Why?
|
| Christianity | 1 | 2009 | 48 | 0.340 |
Why?
|
| Relaxation Therapy | 4 | 2019 | 179 | 0.340 |
Why?
|
| Pain, Postoperative | 6 | 2022 | 1718 | 0.330 |
Why?
|
| Health Promotion | 3 | 2020 | 2208 | 0.330 |
Why?
|
| Osteoprotegerin | 1 | 2009 | 177 | 0.330 |
Why?
|
| Conditioning, Classical | 3 | 2018 | 364 | 0.330 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 1169 | 0.320 |
Why?
|
| Ambulatory Care Facilities | 3 | 2011 | 926 | 0.320 |
Why?
|
| Minority Groups | 2 | 2013 | 1199 | 0.320 |
Why?
|
| Plant Oils | 2 | 2021 | 197 | 0.320 |
Why?
|
| Back Pain | 3 | 2024 | 543 | 0.320 |
Why?
|
| Antidepressive Agents | 3 | 2022 | 2889 | 0.310 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2010 | 148 | 0.310 |
Why?
|
| Reward | 3 | 2020 | 964 | 0.310 |
Why?
|
| Electroacupuncture | 3 | 2017 | 66 | 0.300 |
Why?
|
| Bronchodilator Agents | 1 | 2011 | 506 | 0.300 |
Why?
|
| Cognition | 8 | 2019 | 6948 | 0.300 |
Why?
|
| Epilepsy | 1 | 2023 | 3267 | 0.300 |
Why?
|
| Truth Disclosure | 1 | 2012 | 432 | 0.290 |
Why?
|
| Indians, North American | 1 | 2011 | 355 | 0.290 |
Why?
|
| Peer Review | 1 | 2009 | 218 | 0.290 |
Why?
|
| Yin-Yang | 2 | 2004 | 11 | 0.290 |
Why?
|
| History, 19th Century | 7 | 2012 | 720 | 0.290 |
Why?
|
| Concept Formation | 1 | 2008 | 159 | 0.280 |
Why?
|
| History, 18th Century | 7 | 2009 | 207 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 35 | 2024 | 36247 | 0.280 |
Why?
|
| Pruritus | 3 | 2015 | 377 | 0.280 |
Why?
|
| Attention | 3 | 2013 | 2386 | 0.270 |
Why?
|
| Neovascularization, Physiologic | 4 | 2016 | 1335 | 0.270 |
Why?
|
| Psychotropic Drugs | 1 | 2012 | 882 | 0.270 |
Why?
|
| Publication Bias | 2 | 2011 | 162 | 0.260 |
Why?
|
| Panax | 1 | 2005 | 28 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2019 | 15766 | 0.260 |
Why?
|
| Office Visits | 4 | 2020 | 597 | 0.260 |
Why?
|
| Social Support | 3 | 2012 | 2145 | 0.260 |
Why?
|
| Pilot Projects | 15 | 2022 | 8553 | 0.260 |
Why?
|
| Skin | 3 | 2023 | 4468 | 0.260 |
Why?
|
| Sensation | 3 | 2015 | 331 | 0.260 |
Why?
|
| Analgesics, Opioid | 5 | 2023 | 3762 | 0.260 |
Why?
|
| Culture | 2 | 2008 | 622 | 0.260 |
Why?
|
| Comparative Effectiveness Research | 1 | 2011 | 718 | 0.250 |
Why?
|
| Prejudice | 1 | 2009 | 563 | 0.250 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2007 | 246 | 0.250 |
Why?
|
| Cross-Over Studies | 7 | 2014 | 2061 | 0.250 |
Why?
|
| Periodicals as Topic | 3 | 2012 | 1470 | 0.250 |
Why?
|
| Arm Injuries | 2 | 2022 | 156 | 0.250 |
Why?
|
| Menopause | 3 | 2022 | 1640 | 0.240 |
Why?
|
| Touch Perception | 2 | 2020 | 106 | 0.240 |
Why?
|
| Holistic Health | 2 | 2001 | 46 | 0.240 |
Why?
|
| Cerebral Cortex | 7 | 2023 | 5755 | 0.240 |
Why?
|
| Young Adult | 38 | 2021 | 58673 | 0.240 |
Why?
|
| Patulin | 1 | 2004 | 1 | 0.240 |
Why?
|
| Patient Education as Topic | 4 | 2012 | 2311 | 0.240 |
Why?
|
| Neuralgia | 2 | 2023 | 597 | 0.230 |
Why?
|
| History, 20th Century | 9 | 2012 | 2777 | 0.230 |
Why?
|
| Constipation | 2 | 2019 | 561 | 0.230 |
Why?
|
| Public Health | 3 | 2020 | 2655 | 0.230 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 475 | 0.230 |
Why?
|
| Osteoarthritis, Knee | 4 | 2018 | 1234 | 0.230 |
Why?
|
| Common Cold | 1 | 2004 | 63 | 0.230 |
Why?
|
| Infertility, Female | 1 | 2010 | 760 | 0.230 |
Why?
|
| Quality of Life | 12 | 2023 | 13300 | 0.220 |
Why?
|
| Neurosciences | 1 | 2008 | 353 | 0.220 |
Why?
|
| Diabetic Neuropathies | 1 | 2007 | 406 | 0.220 |
Why?
|
| Arm | 4 | 2011 | 583 | 0.210 |
Why?
|
| Chiropractic | 2 | 2002 | 39 | 0.210 |
Why?
|
| Internationality | 1 | 2008 | 1005 | 0.210 |
Why?
|
| Fatigue | 2 | 2022 | 1544 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2022 | 1076 | 0.210 |
Why?
|
| Gastroesophageal Reflux | 3 | 2015 | 816 | 0.200 |
Why?
|
| Chronic Disease | 11 | 2019 | 9283 | 0.200 |
Why?
|
| Family | 2 | 2019 | 3189 | 0.200 |
Why?
|
| Nonverbal Communication | 1 | 2022 | 63 | 0.200 |
Why?
|
| Risk Assessment | 7 | 2019 | 24086 | 0.190 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 1430 | 0.190 |
Why?
|
| Neurotransmitter Agents | 2 | 2015 | 661 | 0.190 |
Why?
|
| Analysis of Variance | 7 | 2021 | 6242 | 0.190 |
Why?
|
| Nausea | 3 | 2012 | 677 | 0.180 |
Why?
|
| Lateral Thalamic Nuclei | 1 | 2020 | 8 | 0.180 |
Why?
|
| Penicillins | 1 | 2004 | 403 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2015 | 6540 | 0.180 |
Why?
|
| China | 7 | 2022 | 2340 | 0.180 |
Why?
|
| Atropine | 2 | 2019 | 245 | 0.180 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2020 | 43 | 0.180 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 15827 | 0.180 |
Why?
|
| Injections, Intramuscular | 1 | 2022 | 553 | 0.180 |
Why?
|
| Motivation | 3 | 2022 | 1990 | 0.180 |
Why?
|
| Colonic Diseases, Functional | 1 | 1999 | 39 | 0.170 |
Why?
|
| Agnosia | 1 | 2020 | 66 | 0.170 |
Why?
|
| Models, Theoretical | 2 | 2018 | 3561 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 4 | 2010 | 2696 | 0.170 |
Why?
|
| Blood Sedimentation | 1 | 2020 | 234 | 0.170 |
Why?
|
| Analgesics | 4 | 2021 | 1066 | 0.170 |
Why?
|
| Asthma | 4 | 2014 | 6167 | 0.170 |
Why?
|
| Catastrophization | 2 | 2022 | 345 | 0.170 |
Why?
|
| Nurse-Patient Relations | 1 | 2019 | 100 | 0.170 |
Why?
|
| Regression Analysis | 6 | 2014 | 6361 | 0.170 |
Why?
|
| Neurofeedback | 1 | 2019 | 44 | 0.170 |
Why?
|
| Academic Medical Centers | 4 | 2016 | 2753 | 0.160 |
Why?
|
| Drug Therapy | 1 | 2002 | 504 | 0.160 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 509 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2906 | 0.160 |
Why?
|
| United States | 34 | 2017 | 72363 | 0.160 |
Why?
|
| alpha-Tocopherol | 1 | 2019 | 126 | 0.160 |
Why?
|
| Hospitals, Urban | 2 | 2015 | 499 | 0.160 |
Why?
|
| Philosophy | 1 | 2019 | 68 | 0.160 |
Why?
|
| Cocaine-Related Disorders | 1 | 2002 | 460 | 0.160 |
Why?
|
| Food, Organic | 1 | 1998 | 35 | 0.150 |
Why?
|
| Aged | 42 | 2024 | 168995 | 0.150 |
Why?
|
| Cues | 5 | 2014 | 867 | 0.150 |
Why?
|
| Dopamine | 2 | 2018 | 1583 | 0.150 |
Why?
|
| Equipment and Supplies | 1 | 2000 | 275 | 0.150 |
Why?
|
| Personal Autonomy | 2 | 2012 | 302 | 0.150 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2020 | 629 | 0.150 |
Why?
|
| Hot Temperature | 4 | 2015 | 1435 | 0.150 |
Why?
|
| Endothelial Cells | 4 | 2016 | 3537 | 0.140 |
Why?
|
| Tonsillectomy | 2 | 2019 | 268 | 0.140 |
Why?
|
| Massage | 4 | 2015 | 86 | 0.140 |
Why?
|
| Endothelial Growth Factors | 1 | 1999 | 674 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2015 | 3159 | 0.140 |
Why?
|
| Emigrants and Immigrants | 2 | 2015 | 539 | 0.140 |
Why?
|
| Stress, Psychological | 4 | 2019 | 4440 | 0.140 |
Why?
|
| Diclofenac | 1 | 2017 | 67 | 0.140 |
Why?
|
| Xerostomia | 1 | 2017 | 94 | 0.140 |
Why?
|
| Paternalism | 2 | 2012 | 47 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2716 | 0.140 |
Why?
|
| Plants, Medicinal | 2 | 2010 | 165 | 0.140 |
Why?
|
| Germany | 2 | 2010 | 875 | 0.140 |
Why?
|
| Lymphokines | 1 | 1999 | 929 | 0.140 |
Why?
|
| Ephrin-B2 | 1 | 2016 | 40 | 0.140 |
Why?
|
| Conversion Disorder | 1 | 2019 | 202 | 0.130 |
Why?
|
| Receptor, EphB4 | 1 | 2016 | 39 | 0.130 |
Why?
|
| Medical Oncology | 2 | 2019 | 2321 | 0.130 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1998 | 363 | 0.130 |
Why?
|
| Basal Ganglia | 1 | 2019 | 552 | 0.130 |
Why?
|
| Acupressure | 2 | 2010 | 16 | 0.130 |
Why?
|
| Outpatients | 1 | 2004 | 1606 | 0.130 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2022 | 1469 | 0.130 |
Why?
|
| Curriculum | 3 | 2015 | 3722 | 0.130 |
Why?
|
| Peanut Hypersensitivity | 1 | 2019 | 211 | 0.130 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 430 | 0.130 |
Why?
|
| Clonidine | 1 | 2016 | 170 | 0.130 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2016 | 91 | 0.130 |
Why?
|
| Thinking | 1 | 2019 | 319 | 0.130 |
Why?
|
| Cyclosporine | 1 | 2018 | 778 | 0.130 |
Why?
|
| Infertility | 1 | 2022 | 655 | 0.120 |
Why?
|
| Acute Disease | 3 | 2007 | 7268 | 0.120 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2020 | 225 | 0.120 |
Why?
|
| Opiate Substitution Treatment | 1 | 2019 | 435 | 0.120 |
Why?
|
| Serum | 1 | 2016 | 211 | 0.120 |
Why?
|
| Microvessels | 2 | 2016 | 572 | 0.120 |
Why?
|
| Qualitative Research | 4 | 2019 | 2958 | 0.120 |
Why?
|
| Dietary Supplements | 6 | 2019 | 3389 | 0.120 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2016 | 215 | 0.120 |
Why?
|
| Interdisciplinary Communication | 4 | 2008 | 934 | 0.120 |
Why?
|
| Parietal Lobe | 2 | 2012 | 850 | 0.120 |
Why?
|
| Genetics | 1 | 2015 | 114 | 0.120 |
Why?
|
| Tacrolimus | 1 | 2018 | 730 | 0.120 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 582 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 2282 | 0.120 |
Why?
|
| Periaqueductal Gray | 2 | 2015 | 110 | 0.120 |
Why?
|
| Cardiovascular Diseases | 4 | 2019 | 15740 | 0.120 |
Why?
|
| Clinical Protocols | 4 | 2017 | 1439 | 0.120 |
Why?
|
| Clinical Competence | 4 | 2015 | 4786 | 0.120 |
Why?
|
| Anxiety | 7 | 2022 | 4532 | 0.120 |
Why?
|
| Waiting Lists | 2 | 2009 | 754 | 0.110 |
Why?
|
| Neck Muscles | 1 | 2014 | 100 | 0.110 |
Why?
|
| Awareness | 2 | 2015 | 644 | 0.110 |
Why?
|
| Medicine, Ayurvedic | 1 | 2013 | 38 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 495 | 0.110 |
Why?
|
| Decision Making | 4 | 2012 | 3924 | 0.110 |
Why?
|
| Allergens | 2 | 2019 | 1399 | 0.110 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 697 | 0.110 |
Why?
|
| Headache | 1 | 2022 | 1249 | 0.110 |
Why?
|
| Personality | 2 | 2014 | 552 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2018 | 826 | 0.110 |
Why?
|
| Politics | 2 | 2012 | 815 | 0.110 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 532 | 0.110 |
Why?
|
| Dermatitis, Atopic | 3 | 2015 | 710 | 0.110 |
Why?
|
| Interprofessional Relations | 2 | 2016 | 989 | 0.110 |
Why?
|
| Research Support as Topic | 2 | 2008 | 699 | 0.110 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2017 | 303 | 0.110 |
Why?
|
| Physical Fitness | 2 | 2008 | 732 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1178 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2010 | 20048 | 0.110 |
Why?
|
| Shoulder Pain | 1 | 2014 | 147 | 0.110 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2012 | 279 | 0.110 |
Why?
|
| Anisotropy | 2 | 2020 | 1278 | 0.110 |
Why?
|
| Photic Stimulation | 3 | 2014 | 1968 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1999 | 708 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2019 | 1478 | 0.110 |
Why?
|
| Music Therapy | 1 | 2014 | 110 | 0.110 |
Why?
|
| Drug Labeling | 2 | 2014 | 251 | 0.110 |
Why?
|
| Neoplasms | 6 | 2019 | 22066 | 0.100 |
Why?
|
| Sensory Thresholds | 2 | 2020 | 377 | 0.100 |
Why?
|
| Suggestion | 3 | 2019 | 21 | 0.100 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2018 | 1191 | 0.100 |
Why?
|
| Adolescent | 21 | 2022 | 87747 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2015 | 453 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1093 | 0.100 |
Why?
|
| Reference Values | 3 | 2010 | 4920 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 23363 | 0.100 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 1876 | 0.100 |
Why?
|
| Torture | 1 | 2012 | 66 | 0.100 |
Why?
|
| Schools, Medical | 1 | 1998 | 878 | 0.100 |
Why?
|
| Cooperative Behavior | 3 | 2010 | 1500 | 0.100 |
Why?
|
| Nervous System | 1 | 2015 | 543 | 0.100 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 1737 | 0.100 |
Why?
|
| Attitude | 1 | 2016 | 777 | 0.100 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 1428 | 0.100 |
Why?
|
| Orthopedic Procedures | 1 | 2021 | 1262 | 0.090 |
Why?
|
| Libraries | 1 | 2010 | 21 | 0.090 |
Why?
|
| Meridians | 1 | 2010 | 7 | 0.090 |
Why?
|
| Health Personnel | 3 | 2015 | 3310 | 0.090 |
Why?
|
| Hippocampus | 3 | 2014 | 3737 | 0.090 |
Why?
|
| Alpha Rhythm | 1 | 2011 | 109 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2020 | 3763 | 0.090 |
Why?
|
| Medicine, Korean Traditional | 1 | 2010 | 3 | 0.090 |
Why?
|
| Visual Perception | 1 | 2019 | 1374 | 0.090 |
Why?
|
| Rest | 4 | 2019 | 915 | 0.090 |
Why?
|
| Moxibustion | 1 | 2010 | 8 | 0.090 |
Why?
|
| Reproductive Techniques | 1 | 2010 | 41 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 3 | 2014 | 1375 | 0.090 |
Why?
|
| Mentha piperita | 2 | 2021 | 17 | 0.090 |
Why?
|
| Drug Contamination | 1 | 2011 | 152 | 0.090 |
Why?
|
| Thigh | 1 | 2011 | 239 | 0.090 |
Why?
|
| Metals, Heavy | 1 | 2011 | 150 | 0.090 |
Why?
|
| Tumor Necrosis Factors | 1 | 2009 | 106 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 1811 | 0.090 |
Why?
|
| History, 16th Century | 1 | 2009 | 70 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2023 | 6210 | 0.090 |
Why?
|
| Health Care Surveys | 7 | 2011 | 2434 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2018 | 1758 | 0.080 |
Why?
|
| Motor Cortex | 2 | 2007 | 995 | 0.080 |
Why?
|
| Financing, Organized | 2 | 2008 | 204 | 0.080 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 696 | 0.080 |
Why?
|
| Education, Medical | 2 | 2016 | 1728 | 0.080 |
Why?
|
| Electric Stimulation | 2 | 2011 | 1735 | 0.080 |
Why?
|
| Acetaminophen | 1 | 2013 | 553 | 0.080 |
Why?
|
| Administration, Oral | 3 | 2019 | 4044 | 0.080 |
Why?
|
| Consciousness | 1 | 2014 | 601 | 0.080 |
Why?
|
| Documentation | 1 | 2015 | 892 | 0.080 |
Why?
|
| Social Identification | 1 | 2009 | 106 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 2161 | 0.080 |
Why?
|
| Republic of Korea | 2 | 2023 | 567 | 0.080 |
Why?
|
| Rehabilitation | 1 | 2010 | 129 | 0.080 |
Why?
|
| Touch | 1 | 2011 | 312 | 0.080 |
Why?
|
| Pesticides | 1 | 2011 | 292 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3822 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 3483 | 0.080 |
Why?
|
| Consensus | 1 | 2018 | 3106 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2020 | 1394 | 0.080 |
Why?
|
| Illusions | 1 | 2008 | 60 | 0.080 |
Why?
|
| France | 1 | 2009 | 511 | 0.080 |
Why?
|
| Forearm | 2 | 2012 | 429 | 0.080 |
Why?
|
| Lidocaine | 3 | 2018 | 538 | 0.080 |
Why?
|
| Emotions | 3 | 2022 | 2730 | 0.080 |
Why?
|
| Naturopathy | 2 | 2009 | 13 | 0.080 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2008 | 36 | 0.080 |
Why?
|
| Pediatrics | 1 | 2023 | 3587 | 0.080 |
Why?
|
| Pregnancy | 1 | 2010 | 29725 | 0.070 |
Why?
|
| Decision Making, Organizational | 1 | 2008 | 136 | 0.070 |
Why?
|
| Survivors | 2 | 2023 | 2367 | 0.070 |
Why?
|
| Shoulder Joint | 1 | 2014 | 730 | 0.070 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8551 | 0.070 |
Why?
|
| Organizations | 1 | 2008 | 171 | 0.070 |
Why?
|
| Social Values | 1 | 2008 | 225 | 0.070 |
Why?
|
| Delirium | 1 | 2019 | 1651 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2009 | 956 | 0.070 |
Why?
|
| Sociology, Medical | 1 | 2007 | 62 | 0.070 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2007 | 239 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5498 | 0.070 |
Why?
|
| Self Report | 3 | 2019 | 3707 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 5324 | 0.070 |
Why?
|
| Professional Role | 1 | 2009 | 311 | 0.070 |
Why?
|
| Hemiplegia | 1 | 2007 | 136 | 0.070 |
Why?
|
| Social Isolation | 1 | 2009 | 362 | 0.070 |
Why?
|
| Rheumatology | 2 | 2010 | 611 | 0.070 |
Why?
|
| Licensure | 3 | 2002 | 127 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2009 | 1018 | 0.070 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 1810 | 0.070 |
Why?
|
| Leg | 1 | 2011 | 1091 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2012 | 1422 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1666 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2006 | 116 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 1996 | 2178 | 0.070 |
Why?
|
| Citalopram | 1 | 2009 | 402 | 0.070 |
Why?
|
| Phototherapy | 1 | 2009 | 367 | 0.070 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2009 | 489 | 0.060 |
Why?
|
| Fibromyalgia | 1 | 2010 | 398 | 0.060 |
Why?
|
| Social Perception | 1 | 2009 | 431 | 0.060 |
Why?
|
| Quality Control | 2 | 2011 | 827 | 0.060 |
Why?
|
| Time Factors | 7 | 2018 | 40133 | 0.060 |
Why?
|
| Genotype | 3 | 2019 | 12959 | 0.060 |
Why?
|
| Galvanic Skin Response | 1 | 2007 | 348 | 0.060 |
Why?
|
| Musculoskeletal Diseases | 1 | 2011 | 594 | 0.060 |
Why?
|
| Tablets | 1 | 2006 | 149 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2019 | 4649 | 0.060 |
Why?
|
| Parahippocampal Gyrus | 1 | 2006 | 115 | 0.060 |
Why?
|
| Vision, Ocular | 1 | 2009 | 453 | 0.060 |
Why?
|
| Japan | 2 | 2023 | 1369 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 13629 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2009 | 789 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4168 | 0.060 |
Why?
|
| Internet | 2 | 2015 | 3074 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2853 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2020 | 54263 | 0.060 |
Why?
|
| Health Surveys | 2 | 2016 | 4061 | 0.060 |
Why?
|
| Control Groups | 2 | 2010 | 105 | 0.060 |
Why?
|
| Abortion, Spontaneous | 1 | 2010 | 530 | 0.060 |
Why?
|
| Pons | 1 | 2006 | 239 | 0.060 |
Why?
|
| Mind-Body Therapies | 3 | 2016 | 265 | 0.060 |
Why?
|
| Paresis | 1 | 2005 | 177 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 2557 | 0.060 |
Why?
|
| Anesthetics, Local | 3 | 2018 | 1001 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2006 | 186 | 0.060 |
Why?
|
| Health Behavior | 1 | 2016 | 2621 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2009 | 2295 | 0.060 |
Why?
|
| Video Recording | 1 | 2009 | 957 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10829 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2852 | 0.060 |
Why?
|
| Refugees | 1 | 2012 | 598 | 0.060 |
Why?
|
| Bell Palsy | 1 | 2004 | 39 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 759 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3774 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 1375 | 0.060 |
Why?
|
| Psychometrics | 3 | 2012 | 3049 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2016 | 6375 | 0.050 |
Why?
|
| Psychiatry | 1 | 2015 | 1686 | 0.050 |
Why?
|
| Patient Dropouts | 2 | 2019 | 412 | 0.050 |
Why?
|
| Public Opinion | 1 | 2007 | 481 | 0.050 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 25928 | 0.050 |
Why?
|
| Depressive Disorder, Major | 2 | 2012 | 4735 | 0.050 |
Why?
|
| Headache Disorders | 1 | 2005 | 148 | 0.050 |
Why?
|
| Hand Strength | 1 | 2006 | 452 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 4215 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2015 | 3728 | 0.050 |
Why?
|
| England | 1 | 2004 | 526 | 0.050 |
Why?
|
| Parents | 1 | 2016 | 3547 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2010 | 1056 | 0.050 |
Why?
|
| Exanthema | 1 | 2007 | 504 | 0.050 |
Why?
|
| Microcirculation | 1 | 2007 | 1279 | 0.050 |
Why?
|
| Patient-Centered Care | 2 | 2009 | 1416 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2005 | 824 | 0.050 |
Why?
|
| Aspirin | 1 | 2014 | 3365 | 0.050 |
Why?
|
| Vomiting | 2 | 2010 | 649 | 0.050 |
Why?
|
| Skin Temperature | 1 | 2022 | 96 | 0.050 |
Why?
|
| Depression | 1 | 2021 | 8033 | 0.050 |
Why?
|
| Diet Fads | 1 | 2001 | 13 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2008 | 2253 | 0.050 |
Why?
|
| Empiricism | 1 | 2001 | 7 | 0.050 |
Why?
|
| Morphine | 1 | 2006 | 656 | 0.050 |
Why?
|
| Health Status | 2 | 2015 | 4081 | 0.050 |
Why?
|
| Vestibule, Labyrinth | 1 | 2004 | 232 | 0.050 |
Why?
|
| History, Ancient | 1 | 2002 | 211 | 0.050 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 58947 | 0.050 |
Why?
|
| Spiritual Therapies | 1 | 2002 | 60 | 0.050 |
Why?
|
| Echo-Planar Imaging | 1 | 2006 | 657 | 0.050 |
Why?
|
| Linear Models | 2 | 2009 | 5876 | 0.050 |
Why?
|
| Neuropsychological Tests | 2 | 2018 | 7016 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2001 | 145 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2008 | 1045 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2014 | 1693 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2011 | 5960 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2009 | 1089 | 0.050 |
Why?
|
| Vestibular Diseases | 1 | 2004 | 229 | 0.050 |
Why?
|
| Magnetics | 1 | 2004 | 600 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 14482 | 0.050 |
Why?
|
| Homeostasis | 1 | 2011 | 3305 | 0.050 |
Why?
|
| Upper Extremity | 1 | 2005 | 661 | 0.050 |
Why?
|
| Professional Practice | 1 | 2002 | 313 | 0.040 |
Why?
|
| Referral and Consultation | 3 | 2018 | 3598 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2005 | 1166 | 0.040 |
Why?
|
| Child | 9 | 2023 | 79758 | 0.040 |
Why?
|
| Vitalism | 1 | 1998 | 2 | 0.040 |
Why?
|
| Postural Balance | 1 | 2004 | 617 | 0.040 |
Why?
|
| Nature | 1 | 1998 | 15 | 0.040 |
Why?
|
| Spiritualism | 1 | 1998 | 18 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2002 | 787 | 0.040 |
Why?
|
| Otitis Media with Effusion | 1 | 2000 | 114 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 275 | 0.040 |
Why?
|
| Persuasive Communication | 1 | 2019 | 58 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 538 | 0.040 |
Why?
|
| Oxygen | 3 | 2018 | 4189 | 0.040 |
Why?
|
| Mental Health | 1 | 2013 | 3206 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 2731 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2022 | 80301 | 0.040 |
Why?
|
| Cerebellum | 1 | 2006 | 1495 | 0.040 |
Why?
|
| Carbidopa | 1 | 2018 | 30 | 0.040 |
Why?
|
| Cognitive Reserve | 1 | 2019 | 92 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 1381 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1999 | 749 | 0.040 |
Why?
|
| Association | 1 | 2018 | 52 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 12281 | 0.040 |
Why?
|
| Adaptation, Psychological | 3 | 2014 | 2628 | 0.040 |
Why?
|
| Facial Expression | 1 | 2022 | 509 | 0.040 |
Why?
|
| Health Policy | 1 | 2010 | 2678 | 0.040 |
Why?
|
| Observer Variation | 1 | 2004 | 2596 | 0.040 |
Why?
|
| beta Carotene | 1 | 2019 | 524 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2018 | 366 | 0.040 |
Why?
|
| Religion | 1 | 2001 | 376 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 8945 | 0.040 |
Why?
|
| Back | 1 | 1997 | 64 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 21065 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2015 | 3096 | 0.040 |
Why?
|
| Levodopa | 1 | 2018 | 217 | 0.040 |
Why?
|
| Catecholamines | 1 | 2018 | 385 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2022 | 22041 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 2018 | 189 | 0.040 |
Why?
|
| Stem Cells | 1 | 2010 | 3525 | 0.030 |
Why?
|
| Taste | 1 | 2018 | 187 | 0.030 |
Why?
|
| Orthostatic Intolerance | 1 | 2016 | 21 | 0.030 |
Why?
|
| Data Mining | 1 | 2022 | 553 | 0.030 |
Why?
|
| Median Nerve | 1 | 2017 | 132 | 0.030 |
Why?
|
| Alleles | 2 | 2019 | 6900 | 0.030 |
Why?
|
| Diet, Vegetarian | 1 | 1998 | 181 | 0.030 |
Why?
|
| Cholesterol | 1 | 2005 | 2925 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 39254 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 295 | 0.030 |
Why?
|
| Haloperidol | 1 | 2018 | 389 | 0.030 |
Why?
|
| Science | 1 | 1998 | 240 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 2020 | 359 | 0.030 |
Why?
|
| Capsules | 1 | 2016 | 192 | 0.030 |
Why?
|
| Wind | 1 | 2015 | 41 | 0.030 |
Why?
|
| Polysomnography | 1 | 2022 | 1817 | 0.030 |
Why?
|
| Self Care | 1 | 2001 | 793 | 0.030 |
Why?
|
| Government Programs | 2 | 2008 | 280 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2017 | 441 | 0.030 |
Why?
|
| Urban Population | 2 | 2015 | 2021 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2018 | 639 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2022 | 1064 | 0.030 |
Why?
|
| Wrist | 1 | 2017 | 219 | 0.030 |
Why?
|
| Antacids | 1 | 2015 | 94 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2016 | 199 | 0.030 |
Why?
|
| Physician's Role | 1 | 2002 | 920 | 0.030 |
Why?
|
| Subliminal Stimulation | 1 | 2014 | 8 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2001 | 1576 | 0.030 |
Why?
|
| Norway | 1 | 2016 | 497 | 0.030 |
Why?
|
| Vietnam | 1 | 2015 | 411 | 0.030 |
Why?
|
| Organizational Innovation | 2 | 2008 | 536 | 0.030 |
Why?
|
| Perceptual Masking | 1 | 2014 | 90 | 0.030 |
Why?
|
| Personality Tests | 1 | 2014 | 81 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 167 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17766 | 0.030 |
Why?
|
| Capsaicin | 1 | 2015 | 231 | 0.030 |
Why?
|
| Mental Processes | 1 | 2015 | 245 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 859 | 0.030 |
Why?
|
| New England | 2 | 2008 | 1045 | 0.030 |
Why?
|
| Cortical Synchronization | 1 | 2014 | 77 | 0.030 |
Why?
|
| Cell Survival | 2 | 2015 | 5796 | 0.030 |
Why?
|
| Sleep | 2 | 2022 | 4746 | 0.030 |
Why?
|
| Malpractice | 1 | 1998 | 556 | 0.030 |
Why?
|
| Tooth Extraction | 1 | 2015 | 229 | 0.030 |
Why?
|
| Tryptamines | 1 | 2014 | 93 | 0.030 |
Why?
|
| Arthritis | 1 | 1999 | 666 | 0.030 |
Why?
|
| Skin Tests | 1 | 2015 | 637 | 0.030 |
Why?
|
| Professional Competence | 1 | 1996 | 431 | 0.030 |
Why?
|
| Tooth, Impacted | 1 | 2013 | 43 | 0.030 |
Why?
|
| Antipruritics | 1 | 2012 | 31 | 0.030 |
Why?
|
| Data Collection | 3 | 2013 | 3317 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1493 | 0.030 |
Why?
|
| HIV Infections | 1 | 1999 | 17159 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3451 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 10530 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2015 | 292 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 7803 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2014 | 513 | 0.020 |
Why?
|
| Psychophysics | 1 | 2012 | 289 | 0.020 |
Why?
|
| Uncertainty | 1 | 2017 | 754 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2024 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 29636 | 0.020 |
Why?
|
| Forelimb | 1 | 2011 | 115 | 0.020 |
Why?
|
| Cell Movement | 2 | 2015 | 5206 | 0.020 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2363 | 0.020 |
Why?
|
| Hand | 1 | 2017 | 903 | 0.020 |
Why?
|
| Homozygote | 1 | 2016 | 1786 | 0.020 |
Why?
|
| Materia Medica | 1 | 2010 | 14 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 826 | 0.020 |
Why?
|
| Signal Detection, Psychological | 1 | 2011 | 84 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2014 | 597 | 0.020 |
Why?
|
| Animals | 4 | 2018 | 167940 | 0.020 |
Why?
|
| Europe | 1 | 1998 | 3433 | 0.020 |
Why?
|
| Lasers | 1 | 2015 | 952 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2010 | 12156 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2019 | 6182 | 0.020 |
Why?
|
| Anecdotes as Topic | 1 | 2010 | 56 | 0.020 |
Why?
|
| Affect | 1 | 2018 | 1479 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 551 | 0.020 |
Why?
|
| Risk Factors | 4 | 2016 | 74269 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2018 | 1798 | 0.020 |
Why?
|
| Hospitals | 2 | 2015 | 3929 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2005 | 8523 | 0.020 |
Why?
|
| Nurses | 1 | 2019 | 2468 | 0.020 |
Why?
|
| Vitamin E | 1 | 2014 | 872 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2010 | 6797 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15626 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 8157 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1673 | 0.020 |
Why?
|
| Life Style | 1 | 2001 | 3888 | 0.020 |
Why?
|
| Haplotypes | 1 | 2016 | 2764 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 2383 | 0.020 |
Why?
|
| Health Literacy | 1 | 2015 | 440 | 0.020 |
Why?
|
| Pyridines | 1 | 2021 | 2877 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18415 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3605 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2011 | 453 | 0.020 |
Why?
|
| Parkinsonian Disorders | 1 | 2011 | 284 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 372 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12968 | 0.020 |
Why?
|
| Learning | 1 | 2018 | 1733 | 0.020 |
Why?
|
| Motion Perception | 1 | 2012 | 372 | 0.020 |
Why?
|
| Trust | 1 | 2013 | 528 | 0.020 |
Why?
|
| Thalamus | 1 | 2014 | 1041 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 904 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2010 | 416 | 0.020 |
Why?
|
| Crime Victims | 1 | 2012 | 329 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10434 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9282 | 0.020 |
Why?
|
| Judgment | 1 | 2010 | 273 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2009 | 264 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2009 | 299 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2014 | 1233 | 0.020 |
Why?
|
| Nonprescription Drugs | 1 | 2008 | 118 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2018 | 4169 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 1993 | 869 | 0.020 |
Why?
|
| Prevalence | 1 | 2004 | 15687 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 2937 | 0.020 |
Why?
|
| Magnetoencephalography | 1 | 2011 | 634 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4546 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 2494 | 0.020 |
Why?
|
| Disease Management | 1 | 2017 | 2508 | 0.020 |
Why?
|
| Amygdala | 1 | 2014 | 1350 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11902 | 0.020 |
Why?
|
| Language | 1 | 2015 | 1532 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 41317 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2009 | 3335 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 751 | 0.020 |
Why?
|
| Transportation | 1 | 2007 | 214 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 5396 | 0.020 |
Why?
|
| Stroke | 2 | 2007 | 9945 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2020 | 5073 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 2075 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2776 | 0.020 |
Why?
|
| Population | 1 | 2005 | 140 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2009 | 589 | 0.020 |
Why?
|
| Muscle Spasticity | 1 | 2005 | 155 | 0.020 |
Why?
|
| Spirituality | 1 | 2009 | 428 | 0.010 |
Why?
|
| Mass Media | 1 | 2007 | 300 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 23695 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1346 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 5884 | 0.010 |
Why?
|
| Individuality | 1 | 2006 | 300 | 0.010 |
Why?
|
| Prescription Drugs | 1 | 2011 | 630 | 0.010 |
Why?
|
| Motor Skills | 1 | 2007 | 520 | 0.010 |
Why?
|
| Sensory Receptor Cells | 1 | 2009 | 509 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1388 | 0.010 |
Why?
|
| Probability | 1 | 2009 | 2476 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3524 | 0.010 |
Why?
|
| Comorbidity | 2 | 2010 | 10552 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4286 | 0.010 |
Why?
|
| Hospital Departments | 1 | 2003 | 136 | 0.010 |
Why?
|
| MEDLINE | 1 | 2003 | 119 | 0.010 |
Why?
|
| Psychopathology | 1 | 2006 | 427 | 0.010 |
Why?
|
| Arizona | 1 | 2002 | 109 | 0.010 |
Why?
|
| Positron-Emission Tomography | 2 | 2011 | 6457 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 921 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 1840 | 0.010 |
Why?
|
| Massachusetts | 2 | 2008 | 8805 | 0.010 |
Why?
|
| Incidence | 2 | 2014 | 21378 | 0.010 |
Why?
|
| Connecticut | 1 | 2002 | 364 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6017 | 0.010 |
Why?
|
| Washington | 1 | 2002 | 312 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2635 | 0.010 |
Why?
|
| Cohort Effect | 1 | 2001 | 39 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 1679 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2918 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2003 | 389 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2893 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12762 | 0.010 |
Why?
|
| Physicians, Family | 1 | 2002 | 349 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2001 | 614 | 0.010 |
Why?
|
| Logistic Models | 2 | 2009 | 13311 | 0.010 |
Why?
|
| History, Medieval | 1 | 1999 | 62 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12532 | 0.010 |
Why?
|
| Employment | 1 | 2006 | 1111 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 2477 | 0.010 |
Why?
|
| Program Development | 1 | 2005 | 1297 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2005 | 1582 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16543 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13967 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2000 | 1628 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15273 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 1650 | 0.010 |
Why?
|
| Goals | 1 | 2003 | 708 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 2394 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2007 | 2982 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15680 | 0.010 |
Why?
|
| Workload | 1 | 2002 | 846 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 2414 | 0.010 |
Why?
|
| Health Services Research | 1 | 2002 | 1811 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2010 | 8018 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12602 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2003 | 1192 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2003 | 1675 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2005 | 2510 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 4547 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18968 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2001 | 920 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2001 | 1826 | 0.010 |
Why?
|
| Forecasting | 1 | 2003 | 2931 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8551 | 0.010 |
Why?
|
| Hypertension | 1 | 1993 | 8595 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11480 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4900 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2002 | 1939 | 0.010 |
Why?
|
| Students, Medical | 1 | 2003 | 1926 | 0.010 |
Why?
|
| Risk | 1 | 2001 | 9629 | 0.010 |
Why?
|
| General Surgery | 1 | 1999 | 1681 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5507 | 0.000 |
Why?
|
| Child, Preschool | 2 | 2000 | 42034 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9712 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 36030 | 0.000 |
Why?
|